Latest Blog Posts
Navigating MDR: Fresh Insights and Updates

MDSAP Explained: Members, Audit Cycle and Regulator Use
On 18 December 2025, MDSAP documents moved to a new website, mdsap.global, managed by Australia's TGA (FDA). Since 2 February 2026, FDA's Quality Management System

FDA Human Factors Guidance: The 2026 Updates Explained
In May 2026, FDA finalised "Content of Human Factors Information in Medical Device Marketing Submissions", replacing the December 2022 draft (Federal Register notice). In August

EN ISO 13485 Standard Under the MDR
ISO 13485:2016 was last reviewed and confirmed by ISO in 2025, so the 2016 edition remains current. In the EU, its European adoption, EN ISO

EU MDR Classification Rules in Annex VIII
Article 51 of the MDR, Regulation (EU) 2017/745, divides devices into classes I, IIa, IIb and III, using the 22 rules in Annex VIII. MDCG

ISO 27001 Implementation Steps for SaMD
ISO/IEC 27001:2022, the third edition, was published in October 2022. Amendment 1, on climate action changes, followed in February 2024 and is free of charge

What Is State of the Art? Meaning Under the EU MDR
The MDR (Regulation (EU) 2017/745 of 5 April 2017) requires risks to be acceptable "taking into account the generally acknowledged state of the art" (Annex

Summary of Safety and Clinical Performance: MDR Article 32
Regulation (EU) 2017/745 of 5 April 2017, the MDR, introduced the summary of safety and clinical performance (SSCP) in Article 32. On 28 May 2026,

Post Market Surveillance Plan: How to Write It Under EU MDR
The MDR (Regulation (EU) 2017/745) was adopted on 5 April 2017 and has applied since 26 May 2021. Article 84 requires every manufacturer's post-market surveillance

Class 3 Medical Devices: What Class III Means at FDA
The Medical Device Amendments were signed into law on 28 May 1976. Devices first distributed on or after that date are postamendment devices (FDA: PMA